Tandem Diabetes Care Inc (TNDM) - News Archive

As we approach the closing months of 2025, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) finds itself under not only the scrutiny of market analysts but also legal examination regarding its business practices. The Rosen Law...

Tandem Diabetes Secures FDA Approval for Mobile App: A New Era in Insulin Delivery Technology In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a pioneering company in the...

In the ever-evolving landscape of diabetes management, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) continues to forge forward with transformative innovations that are set to redefine patient experiences and outcomes. Base...

In a significant move to enhance diabetes management technologies, Tandem Diabetes Care, Inc. has entered a multi-year research collaboration with the University of Virginia Center for Diabetes Technology. The partnersh...

San Diego Tandem Diabetes Care, Inc. has announced the release of an updated version of its Apple iOS t:connect mobile app, designed specifically for users of the t:slim X2 insulin pump. Scheduled to be available on Aug...

In a significant development for investors in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Bragar Eagel & Squire, P.C., a prominent shareholder rights law firm, has announced that it is investigating potential claims agai...

In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the t:slim X2 insulin pump integrated with the latest Dexcom G7 Continu...

Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM: A Breakthrough in Diabetes Management SAN DIEGO - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) today announced a significant advan...

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023Tandem Diabetes Care, a global insulin delivery and diabetes technology company,...

In a groundbreaking collaboration, Tandem Diabetes Care, Inc., and Abbott have joined forces to integrate their cutting-edge technologies, marking significant advancements in insulin delivery and continuous glucose moni...